Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes
The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11 trial
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.